ACAAI urges CMS to protect allergy practices
Medicare policy must reflect how allergy care is actually delivered and must not create new barriers for small and independent practices.
Making the case for fair allergy immunotherapy policy
The comment period for the proposed 2027 Medicare Physician Fee Schedule closed Sept. 14, and ACAAI made sure the voice of allergy was heard.
UHC touts prior authorization relief
A careful review of the codes finds little that will reduce the everyday administrative burden faced by allergists.
Medicare Advantage appeals process explained
To effectively advocate for their patients and to secure appropriate reimbursement, clinicians must understand the MA appeals framework.
Help us get fair payment for allergy extracts
Together, we and our partners have successfully persuaded Medicare to cover the buildup phase of allergy shots.
The 1% myth
Recent headlines suggest (incorrectly) that prior authorization is no longer the obstacle it once was.
CMS unveils the proposed 2027 Medicare physician fee schedule
CMS has responded to years of ACAAI advocacy by requesting public input on modernizing its allergy immunotherapy policies for CPT code 95165.
2027 CMS Proposal to reduce payment for procedures with E/M visit has minor impact on allergy
Practices that routinely perform nasal endoscopy in conjunction with office visits should review the proposal carefully.
What the 2027 Medicare QPP Proposed Rule would mean for allergy practices
This is the first article in a multi-part series that provides a summary of CMS’s 2027 Medicare Physician Fee Schedule proposed rule.
Doc Caucus working on long-needed Medicare physician payment relief
Bipartisan physician Members of Congress introduced the Patients First Act, a comprehensive legislation to reform Medicare physician payment.
… results in Advocacy Resources.
